Page 6 - Clearpoint Neuro Navigation System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today

United statesMegan faulkenberryJacqueline kellerRaquel rodriguesExchange commissionApplications of the companyClearpoint neuro incCompany clearpoint neuro navigation systemCompany annual report on formPoint neuroNeuro navigationNacional de vigilClearpoint neuro navigation systemPediatric neurosurgeonLatin americaConvection enhanced delivery

ClearPoint Neuro Announces ANVISA Approval of Neuro

SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform.

United statesRaquel rodriguesMegan faulkenberryCompany annual report on formExchange commissionClearpoint neuro incApplications of the companyCompany clearpoint neuro navigation systemPoint neuroNeuro navigationNacional de vigilClearpoint neuro navigation systemPediatric neurosurgeonLatin americaConvection enhanced deliveryVice president

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJacqueline kellerJoe burnettApplications of the companyCompany clearpoint neuro navigation systemExchange commissionClearpoint neuro incCompany annual report on formPoint neuroClearpoint maestroBrain modelPoint maestro brain modelNeuro navigation systemNorth americaClearpoint neuroClearpoint neuro navigation system

ClearPoint Neuro Extends Software License and Research

SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform.

United statesJoe burnettCompany annual report on formCompany clearpoint neuro navigation systemApplications of the companyClearpoint neuro incExchange commissionPoint neuroBrain modelPoint maestro brain modelNeuro navigation systemNorth americaClearpoint neuroClearpoint neuro navigation systemAnnual reportNasdaq clpt

ClearPoint Neuro (CLPT) Enters Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

ClearPoint Neuro (CLPT) Enters Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJacqueline kellerJeremy stigallLaura kurtzmanExchange commissionCalifornia institute for regenerative medicineCompany clearpoint neuro navigation systemClearpoint neuro incCompany annual report on formApplications of the companyWall streetPoint neuroSinnovation venturesOperating roomDaniel limNeurological surgery